Figure 3. Immune microenvironment landscape characteristic in DAG-based molecular subtypes. (A) ESTIMATE score assessment in DAG-based subtypes. (B) Immunotherapy response of LUAD samples in DAG-cluster A and B. (C) Expression of immune checkpoints in DAG-based subtypes. (D) Estimation of immune cells.